Gynecological Endocrinology, 2009 In a clinical pilot study, 21 women with endometriosis have been primarely treated with dienogest 2 x 10 mg daily p.o. for 24 weeks. Besides the effect on endometriosis the action of such high-dose progestogen treatment on the breast was evaluated by breast ultrasound prior to medication and at 24 weeks of medical treatment. In all women, a significant
Adolf E, Schindler +4 more
openaire +2 more sources
Hormonale Kontrazeptiva der zweiten, dritten und vierten Generation: Risiko venöser und arterieller Thrombembolie [PDF]
, 2018 Zusammenfassung: Für die Verschreibung von Ovulationshemmern (OH) sind nicht nur die venösen thrombembolischen Ereignisse entscheidend, sondern die Summe aller Nebenwirkungen.
Birkhäuser, M.
core
A perspective on current research investigating the effects of hormonal contraceptives on determinants of female athlete performance [PDF]
, 2016 Hormonal contraceptives are used by approximately half of female athletes and may affect athletic performance as a result of their action on the endogenous hormonal milieu.
Elliott-Sale, K, Martin, D
core +3 more sources
Polarographic Investigation of Dienogest
Journal of The Electrochemical Society, 2018 Dienogest (DGN), is an orally administered synthetic progestin that has shown to have selective progesterone receptor (PR) agonistic activity and oral progestational potency on endometrium. In this paper, the investigation of electrochemical reduction of Dienogest on dropping mercury electrode (DME) is achieved and resulted in a reduction scheme that ...
Melek Sirin Baymak +4 more
openaire +2 more sources
Hormone replacement therapy in menopause [PDF]
, 2014 Although estrogen has been clinically available for more than six decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT ...
Pardini, Dolores
core +2 more sources
Actualización en anticoncepción hormonal [PDF]
, 2011 La anticoncepción hormonal constituye el segundo método anticonceptivo más utilizado en nuestro país. Las principales novedades en cuanto a composición son la introducción del valerato de estradiol como componente estrogénico para mejorar la seguridad ...
Cuesta Benjumea, R. de la +2 more
core +1 more source
Overview of parametric survival analysis for health-economic applications.
, 2013 Health economic models rely on data from trials to project the risk of events (e.g., death) over time beyond the span of the available data. Parametric survival analysis methods can be applied to identify an appropriate statistical model for the observed
Benedict, Agnes +3 more
core +1 more source
Dienogest versus gonadotropin-releasing hormone analogue for the clinical treatment of endometriosis: a systematic review and meta-analysis [PDF]
, 2017 Endometriosis is a chronic inflammatory disease, defined by the presence of endometrial tissue outside the uterine cavity. It causes symptoms such as dysmenorrhea, chronic pelvic pain, dyspareunia, infertility, with great loss of quality of life for the ...
de Oliveira, Sofia Andrade +2 more
core +2 more sources
Dienogest in long-term treatment of endometriosis [PDF]
, 2011 Endometriosis is a chronic disease primarily affecting women of childbearing age, in which endometriotic lesions form outside the uterus, typically leading to painful symptoms, fatigue, and infertility. The symptoms of endometriosis may cause significant
Schindler, Adolf E
core +3 more sources
Minimally invasive surgery when treating endometriosis has a positive effect on health and on quality of work life of affected women [PDF]
, 2017 STUDY QUESTION What is the effect of the minimally invasive surgical treatment of endometriosis on health and on quality of work life (e.g. working performance) of affected women?
Imboden, S. +3 more
core